| Dr Pasquale A Luciano, DO | |
|
1 Brace Rd Ste H, Cherry Hill, NJ 08034-2600 | |
| (856) 547-0389 | |
| Not Available |
| Full Name | Dr Pasquale A Luciano |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 36 Years |
| Location | 1 Brace Rd Ste H, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861441966 | NPI | - | NPPES |
| 6064108 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 25MB05403700 (New Jersey) | Secondary |
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 25MB05403700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Health Regional Medical Center | Trenton, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Health Medical Group | 7618264532 | 364 |
News Archive
Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.
ExonHit Therapeutics today informs its shareholders that it learned on June 16, 2010 from RedPath Integrated Pathology that Highmark (the Medicare reimbursement regional antenna for the states of Delaware, District of Columbia, Maryland, New Jersey and Pennsylvania) announced its intention to discontinue coverage of PathFinderTG - Pancreatic cancer, contingent to a complementary assessment of the utility of the product.
While previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A, there is little evidence surrounding effects specifically on ovarian function.
Scientists have discovered that that the flu virus can essentially tell time, thereby giving scientists the ability to reset the virus' clock and combat it in more effective ways. According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 5 days ago
| Entity Name | Virtua Surgical Group, P.a |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184811945 PECOS PAC ID: 7315850138 Enrollment ID: O20031107000528 |
News Archive
Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.
ExonHit Therapeutics today informs its shareholders that it learned on June 16, 2010 from RedPath Integrated Pathology that Highmark (the Medicare reimbursement regional antenna for the states of Delaware, District of Columbia, Maryland, New Jersey and Pennsylvania) announced its intention to discontinue coverage of PathFinderTG - Pancreatic cancer, contingent to a complementary assessment of the utility of the product.
While previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A, there is little evidence surrounding effects specifically on ovarian function.
Scientists have discovered that that the flu virus can essentially tell time, thereby giving scientists the ability to reset the virus' clock and combat it in more effective ways. According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 5 days ago
| Entity Name | Cooper Surgical Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427177195 PECOS PAC ID: 3274430764 Enrollment ID: O20031213000037 |
News Archive
Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.
ExonHit Therapeutics today informs its shareholders that it learned on June 16, 2010 from RedPath Integrated Pathology that Highmark (the Medicare reimbursement regional antenna for the states of Delaware, District of Columbia, Maryland, New Jersey and Pennsylvania) announced its intention to discontinue coverage of PathFinderTG - Pancreatic cancer, contingent to a complementary assessment of the utility of the product.
While previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A, there is little evidence surrounding effects specifically on ovarian function.
Scientists have discovered that that the flu virus can essentially tell time, thereby giving scientists the ability to reset the virus' clock and combat it in more effective ways. According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 5 days ago
| Entity Name | Atlanticare Physician Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093829608 PECOS PAC ID: 8527953660 Enrollment ID: O20040218000405 |
News Archive
Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.
ExonHit Therapeutics today informs its shareholders that it learned on June 16, 2010 from RedPath Integrated Pathology that Highmark (the Medicare reimbursement regional antenna for the states of Delaware, District of Columbia, Maryland, New Jersey and Pennsylvania) announced its intention to discontinue coverage of PathFinderTG - Pancreatic cancer, contingent to a complementary assessment of the utility of the product.
While previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A, there is little evidence surrounding effects specifically on ovarian function.
Scientists have discovered that that the flu virus can essentially tell time, thereby giving scientists the ability to reset the virus' clock and combat it in more effective ways. According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 5 days ago
| Entity Name | St. Francis Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487667317 PECOS PAC ID: 5395654404 Enrollment ID: O20071026000439 |
News Archive
Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.
ExonHit Therapeutics today informs its shareholders that it learned on June 16, 2010 from RedPath Integrated Pathology that Highmark (the Medicare reimbursement regional antenna for the states of Delaware, District of Columbia, Maryland, New Jersey and Pennsylvania) announced its intention to discontinue coverage of PathFinderTG - Pancreatic cancer, contingent to a complementary assessment of the utility of the product.
While previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A, there is little evidence surrounding effects specifically on ovarian function.
Scientists have discovered that that the flu virus can essentially tell time, thereby giving scientists the ability to reset the virus' clock and combat it in more effective ways. According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 5 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.
ExonHit Therapeutics today informs its shareholders that it learned on June 16, 2010 from RedPath Integrated Pathology that Highmark (the Medicare reimbursement regional antenna for the states of Delaware, District of Columbia, Maryland, New Jersey and Pennsylvania) announced its intention to discontinue coverage of PathFinderTG - Pancreatic cancer, contingent to a complementary assessment of the utility of the product.
While previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A, there is little evidence surrounding effects specifically on ovarian function.
Scientists have discovered that that the flu virus can essentially tell time, thereby giving scientists the ability to reset the virus' clock and combat it in more effective ways. According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 5 days ago
| Entity Name | Capital Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437516887 PECOS PAC ID: 7618264532 Enrollment ID: O20160921000449 |
News Archive
Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.
ExonHit Therapeutics today informs its shareholders that it learned on June 16, 2010 from RedPath Integrated Pathology that Highmark (the Medicare reimbursement regional antenna for the states of Delaware, District of Columbia, Maryland, New Jersey and Pennsylvania) announced its intention to discontinue coverage of PathFinderTG - Pancreatic cancer, contingent to a complementary assessment of the utility of the product.
While previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A, there is little evidence surrounding effects specifically on ovarian function.
Scientists have discovered that that the flu virus can essentially tell time, thereby giving scientists the ability to reset the virus' clock and combat it in more effective ways. According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pasquale A Luciano, DO 23 Lamson Ln, Sewell, NJ 08080-1897 Ph: () - | Dr Pasquale A Luciano, DO 1 Brace Rd Ste H, Cherry Hill, NJ 08034-2600 Ph: (856) 547-0389 |
News Archive
Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.
ExonHit Therapeutics today informs its shareholders that it learned on June 16, 2010 from RedPath Integrated Pathology that Highmark (the Medicare reimbursement regional antenna for the states of Delaware, District of Columbia, Maryland, New Jersey and Pennsylvania) announced its intention to discontinue coverage of PathFinderTG - Pancreatic cancer, contingent to a complementary assessment of the utility of the product.
While previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A, there is little evidence surrounding effects specifically on ovarian function.
Scientists have discovered that that the flu virus can essentially tell time, thereby giving scientists the ability to reset the virus' clock and combat it in more effective ways. According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 5 days ago
Arthur Ng, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste H, Cherry Hill, NJ 08034 Phone: 856-547-0389 | |
Dr. Arthur Allan Hellman, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 940 Brick Rd, Cherry Hill, NJ 08003 Phone: 856-489-3624 | |
Atiq Ur Rehman, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd, Suite C, Cherry Hill, NJ 08034 Phone: 856-470-9029 Fax: 856-428-4053 | |
Dr. Andrew S Olearchyk, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 129 Walt Whitman Blvd, Cherry Hill, NJ 08003 Phone: 856-428-0505 Fax: 856-428-0505 | |
Dr. Salvatore Michael Moffa, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 3207 Bishops View Cir, Cherry Hill, NJ 08002 Phone: 856-910-2850 | |
Chun W Choi, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste H, Cherry Hill, NJ 08034 Phone: 856-547-0389 |